Sinclair Pharma PLC Company Profile (LON:SPH)

About Sinclair Pharma PLC (LON:SPH)

Sinclair Pharma PLC logoSinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor. The Company's product categories include Aesthetic Care, Skin Care, Wound Care and Non-Dermatology. The Company provides aesthetic dermatology solutions through thread lift, collagen stimulation and dermal fillers. The Company's aesthetic products include Silhouette Soft, Ellanse, Perfectha, Sculptra and USOFT Massage Gel. Its Silhouette Soft is inserted in the subcutaneous tissue. Its USOFT Massage Gel is a gel used for facial massage. It is engaged in research and development, and owns various product rights and licenses in a range of territories in which it trades.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Generic Pharmaceuticals
  • Sub-Industry: N/A
  • Symbol: LON:SPH
  • CUSIP: N/A
  • Web: www.sinclairispharma.com
Capitalization:
  • Market Cap: £145.86 million
  • Outstanding Shares: 502,953,000
Average Prices:
  • 50 Day Moving Avg: GBX 27.42
  • 200 Day Moving Avg: GBX 30.21
  • 52 Week Range: GBX 25.25 - GBX 36.35
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: £33.13 million
  • Price / Sales: 4.40
  • Book Value: GBX 0.19 per share
  • Price / Book: 1.53
Profitability:
  • EBITDA: ($11,090,000.00)
  • Net Margins: -35.58%
  • Return on Equity: -14.73%
  • Return on Assets: -8.12%
Misc:
  • Average Volume: 482,948 shs.
 

Frequently Asked Questions for Sinclair Pharma PLC (LON:SPH)

What is Sinclair Pharma PLC's stock symbol?

Sinclair Pharma PLC trades on the London Stock Exchange (LON) under the ticker symbol "SPH."

Where is Sinclair Pharma PLC's stock going? Where will Sinclair Pharma PLC's stock price be in 2017?

6 equities research analysts have issued 12-month price objectives for Sinclair Pharma PLC's stock. Their forecasts range from GBX 35 to GBX 71. On average, they anticipate Sinclair Pharma PLC's share price to reach GBX 54 in the next year. View Analyst Ratings for Sinclair Pharma PLC.

Who are some of Sinclair Pharma PLC's key competitors?

Who are Sinclair Pharma PLC's key executives?

Sinclair Pharma PLC's management team includes the folowing people:

  • Christopher P. Spooner, Chief Executive Officer, Executive Director
  • Alan Olby, Chief Financial Officer
  • Jean-Louis Lamande, Operations Finance Director
  • Jayne Burrell, Group General Counsel, Company Secretary
  • Patrick Khoukaz, Head - European Operations and Global Aesthetics
  • Sarb Klair, Head - Corporate Development
  • Nairn McMaster, Head - Business Development
  • Grahame David Cook, Non-Executive Independent Chairman of the Board
  • Jean-Charles Tschudin, Senior Non-Executive Independent Director

How do I buy Sinclair Pharma PLC stock?

Shares of Sinclair Pharma PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Sinclair Pharma PLC's stock price today?

One share of Sinclair Pharma PLC stock can currently be purchased for approximately GBX 29.


MarketBeat Community Rating for Sinclair Pharma PLC (LON SPH)
Community Ranking:  3.9 out of 5 (star star star)
Outperform Votes:  312 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  399
MarketBeat's community ratings are surveys of what our community members think about Sinclair Pharma PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Sinclair Pharma PLC (LON:SPH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: GBX 54
Consensus Price Target History for Sinclair Pharma PLC (LON:SPH)
Price Target History for Sinclair Pharma PLC (LON:SPH)
Analysts' Ratings History for Sinclair Pharma PLC (LON:SPH)
Show:
DateFirmActionRatingPrice TargetDetails
10/23/2017Peel HuntReiterated RatingBuyGBX 68View Rating Details
9/29/2017Jefferies Group LLCReiterated RatingBuyGBX 55View Rating Details
9/19/2017N+1 SingerReiterated RatingBuyGBX 37View Rating Details
7/11/2017Stifel NicolausReiterated RatingBuyGBX 71View Rating Details
4/4/2017Numis Securities LtdReiterated RatingHoldGBX 35View Rating Details
11/18/2016Canaccord GenuityReiterated RatingBuyGBX 58View Rating Details
9/15/2016Royal Bank Of CanadaReiterated RatingOutperformView Rating Details
(Data available from 10/23/2015 forward)

Earnings

Earnings History for Sinclair Pharma PLC (LON:SPH)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Sinclair Pharma PLC (LON:SPH)
Current Year EPS Consensus Estimate: $-1.93 EPS

Dividends

Dividend History for Sinclair Pharma PLC (LON:SPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Sinclair Pharma PLC (LON:SPH)
Insider Trades by Quarter for Sinclair Pharma PLC (LON:SPH)
Insider Trades by Quarter for Sinclair Pharma PLC (LON:SPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/14/2016Alan OlbyInsiderBuy6,748GBX 29£1,956.92
10/4/2016Jeff ThompsonInsiderBuy150,000GBX 29£43,500
5/27/2016Tschudin,Jean-CharlesInsiderBuy97,000GBX 36£34,920
5/26/2016Tschudin,Jean-CharlesInsiderBuy3,023GBX 35£1,058.05
5/23/2016Olby,AlanInsiderBuy50,000GBX 35£17,500
5/20/2016Foucher,ChristopheInsiderBuy31,500GBX 35£11,025
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Sinclair Pharma PLC (LON:SPH)
Latest Headlines for Sinclair Pharma PLC (LON:SPH)
Source:
Loading headlines, please wait.

Social

Social activity is not available for this stock.

Chart

Sinclair Pharma PLC (SPH) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.